Susquehanna International Group
CBMG

Susquehanna International Group’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Susquehanna International Group’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-83,121
Closed -$1.53M – 13225
2020
Q4 		$1.53M Buy
83,121
+48,897
+143% +$891K ﹤0.01% 5704
2020
Q3 		$628K Buy
+34,224
New +$575K ﹤0.01% 7197
2018
Q2 		– Sell
-43,028
Closed -$755K – 10760
2018
Q1 		$755K Buy
+43,028
New +$788K ﹤0.01% 5801
2017
Q3 		– Sell
-36,573
Closed -$320K – 9959
2017
Q2 		$320K Buy
+36,573
New +$322K ﹤0.01% 7475
2017
Q1 		– Sell
-24,584
Closed -$322K – 10409
2016
Q4 		$322K Buy
+24,584
New +$329K ﹤0.01% 7837
2015
Q2 		– Sell
-21,270
Closed -$669K – 10623
2015
Q1 		$669K Buy
+21,270
New +$575K ﹤0.01% 6578

Susquehanna International Group's CBMG Position: Q1 2021 in Review

Susquehanna International Group sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 83,121 shares — an estimated $1.53M sold.

Susquehanna International Group first reported a position in CBMG in Q1 2015 and held it in 6 quarters. The position peaked at $1.53M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Susquehanna International Group reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Susquehanna International Group sold 83,121 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $1.53M.
  • Susquehanna International Group first reported a position in Cellular Biomedicine Group, Inc. in Q1 2015 and held it in 6 quarters.
  • Susquehanna International Group's Cellular Biomedicine Group, Inc. position peaked at $1.53M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Susquehanna International Group's 13F filing for Q1 2021, filed 17 May 2021.